# Yashvant G. Khaire – FDA Inspection, Nov 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/yashvant-g-khaire/ffa17592-db36-487a-873d-145d68125bb9
Source feed: FDA_Inspections

> FDA inspection 1293416 of Yashvant G. Khaire, November 13, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293416
- Company Name: Yashvant G. Khaire
- Inspection Date: 2025-11-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1206830 - 2023-06-02](https://www.keypedia.com/records/fda_inspections/yashvant-g-khaire/dd485280-af37-45ab-ad3b-90966cf160c6)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chinyere-a-asanya/5d417b03-0ebb-4903-9626-3528d9d95536)
- [Company Rep](https://www.keypedia.com/people/scott-b-laufenberg/ff95c69f-5ee2-4761-b4ef-8b8137c3d963)

Company: https://www.keypedia.com/companies/yashvant-g-khaire/2147f2dd-46d8-43f4-b61b-ce314aab58b3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c